- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT07649707
Preparatory Lifestyle Program Before Functional Restoration for Chronic Low Back Pain (PFRP-FRP)
A Preparatory Lifestyle-Based Physical Activity Intervention Before Intensive Rehabilitation for Chronic Low Back Pain: A Controlled Clinical Study
Chronic low back pain is a major public health issue worldwide, affecting hundreds of millions of people. Intensive multidisciplinary rehabilitation programs, such as the Functional Restoration Program (FRP), are effective in improving physical capacity, quality of life, and return to work in these patients. However, many patients reach these programs in a deconditioned state and may struggle to engage fully with the intensive demands. Additionally, during the waiting period before entering such programs, patients often receive no structured support, which may worsen sedentary behavior and physical deconditioning.
This study examined whether adding a 12-week preparatory phase before the FRP could help patients enter the intensive program in better condition and prevent deterioration during the waiting period. The preparatory phase, called PFRP, was designed as a lifestyle-based intervention emphasizing patient autonomy: participants attended one 2-hour supervised session per week at the Day Hospital and were encouraged to practice exercises at home between sessions. The program also included therapeutic education about pain and self-management strategies.
Twenty-four adults with chronic low back pain were included in two groups. The PFRP group (14 participants) received the 12-week preparatory phase followed by the 4-week FRP. The control group (10 participants) received the FRP alone after an equivalent waiting period. Assessments were conducted at four time points: at the start of the preparatory phase or waiting period (T0), at FRP entry (T1), at FRP exit (T2), and four months after FRP completion (T3).
The two co-primary outcomes were sedentary behavior (measured by the ONAPS questionnaire) and the impact of pain on daily activities (measured by the DALLAS questionnaire). Secondary outcomes included physical fitness, fear-avoidance beliefs, pain intensity, and psychological well-being. The study aimed to evaluate (1) whether the preparatory phase prevents behavioral and functional deterioration during the waiting period, and (2) whether it supports better medium-term maintenance of improvements after the intensive program.
연구 개요
상태
상세 설명
Background and rationale
Chronic low back pain is a leading cause of disability worldwide. Intensive multidisciplinary Functional Restoration Programs (FRP), introduced in France in the 1990s, deliver comprehensive physical, psychological, and cognitive-behavioral care over a short period and have demonstrated effectiveness on physical capacity, quality of life, and return to work. As these programs have opened to broader patient populations, marked disparities in therapeutic response have emerged. Several factors may explain heterogeneity in outcomes: differences in baseline deconditioning, severe kinesiophobia, professional and family constraints limiting adherence after discharge, and the difficulty of transferring acquired skills to daily life. The waiting period before program entry is often unstructured, with no specific intervention provided, potentially allowing sedentary behavior and physical deconditioning to progress.
A preparatory phase grounded in adapted physical activity, hereafter referred to as PFRP, was developed to address these gaps. The PFRP follows a lifestyle-based approach centered on patient autonomy and self-directed practice, aiming to (1) prepare deconditioned patients physically and psychologically for the intensive program, and (2) develop self-management skills earlier in the care pathway to facilitate transfer of acquired behaviors after program completion. To our knowledge, no previous study has examined a preparatory phase prior to a conservative functional restoration program; prehabilitation research has focused primarily on pre-surgical contexts.
Study design
This was a prospective, controlled, non-randomized, single-center study conducted in a rehabilitation center in northern France. Participants were assigned to one of two groups according to admission scheduling and organizational constraints of the residential program (groups of 2 to 6 patients). Randomization was not feasible due to the longitudinal nature of the study and admission logistics. Identical inclusion and exclusion criteria were applied to both groups to limit selection bias.
Interventions
PFRP group: 12-week preparatory phase delivered in group format at the Day Hospital, totaling 26 hours of therapeutic exposure (2-hour initial assessment, weekly 2-hour supervised sessions until FRP entry, 4 hours dedicated to exercise learning, 2 hours of therapeutic education). Approximately 18 hours of autonomous practice at home were prescribed (69% of total exposure). Supervised sessions, led by an Adapted Physical Activity Instructor, included resistance training at 60% of 3-repetition maximum, mobilization and stretching, and cardiorespiratory training on an ergocycle. Sessions were scheduled at the end of the day to accommodate working participants. Therapeutic education addressed misconceptions about pain and self-management strategies. After the 12-week phase, PFRP participants entered the 4-week intensive FRP.
FRP group: 4-week intensive program in a group setting at the Day Hospital, totaling 117 hours (34 hours of independent training, 76.5 hours of supervised group sessions including physiotherapy, occupational therapy, adapted physical activities, balneotherapy, and stretching). Four weekly therapeutic education sessions addressed pain perception, post-program physical activity planning, and exercise physiology. The FRP group received no structured intervention during the waiting period equivalent to the PFRP phase.
Assessments
Outcomes were assessed at four time points: T0 (start of preparatory phase or waiting period), T1 (FRP entry), T2 (FRP exit), and T3 (4-month follow-up).
Co-primary outcomes were selected a priori based on the theoretical framework of the intervention: (1) sedentary behavior measured by the ONAPS-SED subscale, as a direct measure of the behavioral change targeted by the intervention, and (2) impact of pain on Daily Activities measured by the DALLAS-DA subscale, reflecting functional autonomy in everyday life. The ONAPS questionnaire was not administered at T2 because intensive hospitalization does not reflect habitual physical activity behavior.
Secondary outcomes were organized by hypothesized mechanism: other DALLAS subscales (Work/Leisure Activities, Anxiety/Depression, Social interest), other ONAPS subscales (total physical activity, Moderate-to-Vigorous Physical Activity Intensity), functional disability (EIFEL), cognitive mediators (fear-avoidance beliefs about physical activity and work, FABQ-PA and FABQ-W), physical fitness (trunk muscular endurance via Sorensen, Ito-Shirado, lateral plank, and Killy tests; trunk and hamstring mobility; isokinetic trunk flexor/extensor strength at 30°/s and 90°/s), pain intensity (Visual Analog Scale), and psychological well-being (GHQ-12).
Statistical analyses
Sample size was estimated a priori using G*Power for a repeated-measures ANOVA within-between interaction (2 groups, 4 timepoints, medium effect size f=0.25, α=0.05, power=0.70), yielding a minimum of 22 participants; 24 were enrolled to account for attrition. Given the small sample size and non-normal distributions, non-parametric tests were used: Wilcoxon signed-rank for intra-group comparisons, Mann-Whitney U for inter-group comparisons and Group × Time interactions on change scores. Effect sizes were reported as rank-biserial correlations. The Benjamini-Hochberg procedure was applied to control the false discovery rate. Missing data (2.4%) were imputed using last observation carried forward following intention-to-treat principles.
Registration note
This study was retrospectively registered on ClinicalTrials.gov. Registration was not performed prior to enrolment because the study was classified as non-interventional research under French legislation (Loi Jardé) and received ethics approval under that framework. The requirement for prospective registration under ICMJE criteria, which apply a broader definition of clinical trial including non-randomised controlled studies with prospective allocation, was identified only at the manuscript preparation stage. The outcomes registered correspond exactly to those defined a priori in the study protocol and reported in the resulting manuscript.
연구 유형
등록 (실제)
단계
- 해당 없음
연락처 및 위치
연구 장소
-
-
-
Raimbeaucourt, 프랑스, 59283
- Centre Hélène Borel
-
-
참여기준
자격 기준
공부할 수 있는 나이
- 성인
- 고령자
건강한 자원 봉사자를 받아들입니다
설명
Inclusion Criteria:
- Low back pain lasting more than three months (chronic low back pain)
- Previous treatment failure (e.g., ineffective physical therapy)
- For participants over 40 years of age: completion of a cardiovascular stress test to rule out any cardiovascular risk
- Aged 18 to 65 years
- Written informed consent provided prior to inclusion
Exclusion Criteria:
- Spinal or related surgery within the six months prior to entering the program
- Under 18 or over 65 years of age
- Previous participation in a similar multidisciplinary rehabilitation program
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위화되지 않음
- 중재 모델: 병렬 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: Preparatory program followed by Functional Restoration Program (PFRP)
Participants received a 12-week preparatory lifestyle-based intervention (PFRP) followed by the 4-week intensive Functional Restoration Program (FRP).
The PFRP totaled 26 hours of therapeutic exposure, including a 2-hour initial assessment, weekly 2-hour supervised sessions at the Day Hospital, 4 hours dedicated to exercise learning, 2 hours of therapeutic education, and approximately 18 hours of autonomous practice at home (69% of total exposure).
The PFRP was designed as a gradual preparation phase emphasizing patient autonomy and self-management skills.
After completing the 12-week PFRP, participants entered the 4-week intensive FRP.
|
A 12-week preparatory phase delivered in group format at the Day Hospital, totaling 26 hours of therapeutic exposure.
The program included a 2-hour initial assessment, weekly 2-hour supervised sessions led by an Adapted Physical Activity Instructor, 4 hours dedicated to exercise learning, and 2 hours of therapeutic education.
Approximately 18 hours of autonomous practice at home were prescribed (69% of total exposure).
Supervised sessions, scheduled at the end of the day to accommodate working participants, comprised resistance training on weight machines at 60% of three-repetition maximum, mobilization and stretching, and cardiorespiratory training on an ergocycle.
Therapeutic education addressed misconceptions about pain and self-management strategies.
The exercise content mirrored that of the subsequent Functional Restoration Program.
다른 이름들:
|
|
활성 비교기: Functional Restoration Program alone (FRP)
Participants received the 4-week intensive Functional Restoration Program (FRP) alone, after an equivalent waiting period without structured intervention.
The FRP comprised 117 hours of multidisciplinary care delivered in a group setting at the Day Hospital (34 hours of independent training and 76.5 hours of supervised sessions including group physiotherapy, occupational therapy, adapted physical activities, balneotherapy, and stretching).
Four weekly therapeutic education sessions addressed pain perception, post-program physical activity planning, and exercise physiology.
|
A 4-week intensive multidisciplinary program delivered in a group setting at the Day Hospital, totaling 117 hours.
Independent training (34 hours, average 6-7 hours per day) included muscle strengthening on weight machines (6-10 sets of 10 repetitions at 60% of three-repetition maximum, recalibrated midway through the program) and cardiorespiratory endurance on an ergocycle (20 minutes at 50% resistance during an incremental submaximal test).
Supervised sessions (76.5 hours) comprised group physiotherapy (mobility, progressive strengthening), occupational therapy (flexion/extension, rotations, load carrying), adapted physical activities (physical games followed by core strengthening routines from the third week), balneotherapy, and stretching.
Four weekly therapeutic education sessions addressed pain perception, post-program physical activity planning, and exercise physiology.
다른 이름들:
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Change in sedentary behavior (ONAPS-SED)
기간: Baseline (T0), 12 weeks (T1, FRP entry / end of preparatory phase), and approximately 8 months post-baseline (T3, 4-month follow-up after FRP completion)
|
Sedentary behavior measured by the Sedentary subscale of the French ONAPS Physical Activity Questionnaire (ONAPS-PAQ), expressed in minutes per week.
This subscale captures habitual sedentary time and was selected a priori as a direct measure of the behavioral change targeted by the lifestyle-based intervention.
ONAPS-SED was not administered at T2 because intensive hospitalization does not reflect habitual physical activity behavior; analyses therefore focused on the T0-T1 (preparatory phase / waiting period) and T0-T3 (overall) periods.
|
Baseline (T0), 12 weeks (T1, FRP entry / end of preparatory phase), and approximately 8 months post-baseline (T3, 4-month follow-up after FRP completion)
|
|
Change in impact of pain on Daily Activities (DALLAS-DA)
기간: Baseline (T0), 12 weeks (T1, FRP entry), 16 weeks (T2, FRP exit), and approximately 8 months post-baseline (T3, 4-month follow-up)
|
Functional impact of pain on Daily Activities measured by the DALLAS Pain Questionnaire (Daily Activities subscale), expressed as a percentage from 0% (no impact) to 100% (maximum impact).
This subscale was selected a priori as a measure of functional autonomy in everyday life, in line with the lifestyle-based intervention's theoretical framework.
|
Baseline (T0), 12 weeks (T1, FRP entry), 16 weeks (T2, FRP exit), and approximately 8 months post-baseline (T3, 4-month follow-up)
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Change in functional disability (EIFEL)
기간: Baseline (T0), 12 weeks (T1), 16 weeks (T2), and approximately 8 months post-baseline (T3)
|
Functional disability related to low back pain measured by the EIFEL questionnaire (French validated version of the Roland-Morris Disability Questionnaire), ranging from 0 (no disability) to 24 (maximum disability).
|
Baseline (T0), 12 weeks (T1), 16 weeks (T2), and approximately 8 months post-baseline (T3)
|
|
Change in pain intensity (VAS)
기간: Baseline (T0), 12 weeks (T1), 16 weeks (T2), and approximately 8 months post-baseline (T3)
|
Self-reported pain intensity over the last three days measured using a 10 cm Visual Analog Scale (VAS), ranging from 0 (no pain) to 10 (maximum pain), without distinction between types of pain (nociceptive, neuropathic, nociplastic, or mixed).
|
Baseline (T0), 12 weeks (T1), 16 weeks (T2), and approximately 8 months post-baseline (T3)
|
|
Change in psychological well-being (GHQ-12)
기간: Baseline (T0), 12 weeks (T1), 16 weeks (T2), and approximately 8 months post-baseline (T3)
|
General psychological well-being measured by the General Health Questionnaire 12-item version (GHQ-12).
Each item scored 1-4; total 12-48.
Higher scores indicate poorer psychological well-being.
|
Baseline (T0), 12 weeks (T1), 16 weeks (T2), and approximately 8 months post-baseline (T3)
|
|
Change in DALLAS work and leisure activities (DALLAS-WLA)
기간: Baseline (T0), 12 weeks (T1), 16 weeks (T2), ~8 months (T3)
|
Impact of pain on work and leisure activities (DALLAS Pain Questionnaire, Work/Leisure subscale), as a percentage from 0% (no impact) to 100% (maximum impact).
Higher values indicate greater impact (worse).
|
Baseline (T0), 12 weeks (T1), 16 weeks (T2), ~8 months (T3)
|
|
Change in DALLAS anxiety/depression (DALLAS-A/D)
기간: Baseline (T0), 12 weeks (T1), 16 weeks (T2), ~8 months (T3)
|
Impact of pain on anxiety and depression (DALLAS Pain Questionnaire, Anxiety/Depression subscale), 0% to 100%.
Higher values indicate greater impact (worse).
|
Baseline (T0), 12 weeks (T1), 16 weeks (T2), ~8 months (T3)
|
|
Change in DALLAS social interest (DALLAS-SOC)
기간: Baseline (T0), 12 weeks (T1), 16 weeks (T2), ~8 months (T3)
|
Impact of pain on social interest (DALLAS Pain Questionnaire, Social subscale), 0% to 100%.
Higher values indicate greater impact (worse).
|
Baseline (T0), 12 weeks (T1), 16 weeks (T2), ~8 months (T3)
|
|
Change in total physical activity (ONAPS-TOT)
기간: Baseline (T0), 12 weeks (T1), ~8 months (T3)
|
Total weekly physical activity (French ONAPS-PAQ), in minutes per week.
Not administered at T2 (intensive hospitalization does not reflect habitual activity).
Higher values indicate more activity.
|
Baseline (T0), 12 weeks (T1), ~8 months (T3)
|
|
Change in moderate-to-vigorous physical activity (ONAPS-MVPAI)
기간: Baseline (T0), 12 weeks (T1), ~8 months (T3)
|
Moderate-to-vigorous physical activity intensity (French ONAPS-PAQ), in minutes per week.
Not administered at T2.
Higher values indicate more activity.
|
Baseline (T0), 12 weeks (T1), ~8 months (T3)
|
|
Change in fear-avoidance beliefs about physical activity (FABQ-PA)
기간: Baseline (T0), 12 weeks (T1), 16 weeks (T2), ~8 months (T3)
|
Fear-Avoidance Beliefs Questionnaire, Physical Activity subscale (4 items), score 0-24.
Higher scores indicate stronger (more deleterious) fear-avoidance beliefs (worse).
|
Baseline (T0), 12 weeks (T1), 16 weeks (T2), ~8 months (T3)
|
|
Change in fear-avoidance beliefs about work (FABQ-W)
기간: Baseline (T0), 12 weeks (T1), 16 weeks (T2), ~8 months (T3)
|
Fear-Avoidance Beliefs Questionnaire, Work subscale (7 items), score 0-42.
Higher scores indicate stronger (more deleterious) fear-avoidance beliefs (worse).
|
Baseline (T0), 12 weeks (T1), 16 weeks (T2), ~8 months (T3)
|
|
Change in finger-to-floor distance
기간: Time Frame: Baseline (T0), 12 weeks (T1), 16 weeks (T2), and approximately 8 months post-baseline (T3, 4-month follow-up)
|
Posterior chain flexibility (finger-to-floor distance test), in centimeters; best of three trials.
Negative values = fingertips below foot level.
Lower values indicate greater mobility.
|
Time Frame: Baseline (T0), 12 weeks (T1), 16 weeks (T2), and approximately 8 months post-baseline (T3, 4-month follow-up)
|
|
Change in lateral trunk mobility
기간: Time Frame: Baseline (T0), 12 weeks (T1), 16 weeks (T2), and approximately 8 months post-baseline (T3, 4-month follow-up)
|
Lumbar lateral mobility: change in finger-to-floor distance between neutral standing and maximal lateral inclination, in centimeters; best of three trials.
Higher values indicate greater lateral mobility.
|
Time Frame: Baseline (T0), 12 weeks (T1), 16 weeks (T2), and approximately 8 months post-baseline (T3, 4-month follow-up)
|
|
Change in trunk rotation
기간: Time Frame: Baseline (T0), 12 weeks (T1), 16 weeks (T2), and approximately 8 months post-baseline (T3, 4-month follow-up)
|
Trunk axial rotation amplitude on a graduated device with pelvis stabilized, right and left, in degrees (0-90° per side); best of three trials.
Higher values indicate greater rotational mobility.
|
Time Frame: Baseline (T0), 12 weeks (T1), 16 weeks (T2), and approximately 8 months post-baseline (T3, 4-month follow-up)
|
|
Change in hamstring extensibility (popliteal angle)
기간: Time Frame: Baseline (T0), 12 weeks (T1), 16 weeks (T2), and approximately 8 months post-baseline (T3, 4-month follow-up)
|
Hamstring extensibility (knee-extension / popliteal angle test, hip flexed 90°): maximal knee-extension amplitude, in degrees; best of three trials.
Higher values indicate greater extensibility.
|
Time Frame: Baseline (T0), 12 weeks (T1), 16 weeks (T2), and approximately 8 months post-baseline (T3, 4-month follow-up)
|
|
Change in trunk extensor peak torque at 30°/s
기간: Baseline (T0), 12 weeks (T1), 16 weeks (T2), and approximately 8 months post-baseline (T3)
|
Trunk extensor peak torque on a Contrex® dynamometer at 30°/s, gravity-corrected and normalized to body weight (Nm/kg); best of three maximal repetitions.
Higher values indicate greater strength.
|
Baseline (T0), 12 weeks (T1), 16 weeks (T2), and approximately 8 months post-baseline (T3)
|
|
Change in trunk extensor peak torque at 90°/s
기간: Baseline (T0), 12 weeks (T1), 16 weeks (T2), and approximately 8 months post-baseline (T3)
|
Trunk extensor peak torque on a Contrex® dynamometer at 90°/s, gravity-corrected and normalized to body weight (Nm/kg); best of three maximal repetitions.
Higher values indicate greater strength.
|
Baseline (T0), 12 weeks (T1), 16 weeks (T2), and approximately 8 months post-baseline (T3)
|
|
Change in trunk flexor peak torque at 30°/s
기간: Baseline (T0), 12 weeks (T1), 16 weeks (T2), and approximately 8 months post-baseline (T3)
|
Trunk flexor peak torque on a Contrex® dynamometer at 30°/s, gravity-corrected and normalized to body weight (Nm/kg); best of three maximal repetitions.
Higher values indicate greater strength.
|
Baseline (T0), 12 weeks (T1), 16 weeks (T2), and approximately 8 months post-baseline (T3)
|
|
Change in trunk flexor peak torque at 90°/s
기간: Baseline (T0), 12 weeks (T1), 16 weeks (T2), and approximately 8 months post-baseline (T3)
|
Trunk flexor peak torque on a Contrex® dynamometer at 90°/s, gravity-corrected and normalized to body weight (Nm/kg); best of three maximal repetitions.
Higher values indicate greater strength.
|
Baseline (T0), 12 weeks (T1), 16 weeks (T2), and approximately 8 months post-baseline (T3)
|
|
Change in trunk flexor endurance (Ito-Shirado test)
기간: Baseline (T0), 12 weeks (T1), 16 weeks (T2), and approximately 8 months post-baseline (T3)
|
Isometric endurance of trunk flexors (Ito-Shirado test), in seconds (0-180).
Higher values indicate greater endurance.
|
Baseline (T0), 12 weeks (T1), 16 weeks (T2), and approximately 8 months post-baseline (T3)
|
|
Change in lateral trunk endurance (McGill side-bridge test)
기간: Baseline (T0), 12 weeks (T1), 16 weeks (T2), and approximately 8 months post-baseline (T3)
|
Isometric endurance of lateral trunk muscles and hip abductors/adductors (McGill side-bridge test), per side, in seconds (0-180).
Higher values indicate greater endurance.
|
Baseline (T0), 12 weeks (T1), 16 weeks (T2), and approximately 8 months post-baseline (T3)
|
|
Change in lower-limb static endurance (Killy test)
기간: Baseline (T0), 12 weeks (T1), 16 weeks (T2), and approximately 8 months post-baseline (T3)
|
Static lower-limb endurance (Killy test: back to wall, hips and knees at 90°), in seconds (0-180).
Higher values indicate greater endurance.
|
Baseline (T0), 12 weeks (T1), 16 weeks (T2), and approximately 8 months post-baseline (T3)
|
|
Change in trunk extensor endurance (Sorensen test)
기간: Baseline (T0), 12 weeks (T1), 16 weeks (T2), and approximately 8 months post-baseline (T3)
|
Isometric endurance of trunk extensors (Sorensen test), in seconds (0-180).
Test stopped after three posture corrections or unbearable pain.
Higher values indicate greater endurance.
|
Baseline (T0), 12 weeks (T1), 16 weeks (T2), and approximately 8 months post-baseline (T3)
|
공동 작업자 및 조사자
간행물 및 유용한 링크
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
키워드
추가 관련 MeSH 약관
기타 연구 ID 번호
- PFRP-FRP-CHB-2023
- 2025-01-07/2025-51 (기타 식별자: CERNI, Université de Picardie Jules Verne (Ethics Committee approval number))
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
IPD 계획 설명
IPD 공유 기간
IPD 공유 액세스 기준
IPD 공유 지원 정보 유형
- 연구_프로토콜
- 수액
- ICF
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
하부 요통에 대한 임상 시험
-
FibroGenAstraZeneca; Astellas Pharma Inc종료됨빈혈증 | 기본 MDS(Very Low, Low 또는 Intermediate IPSS-R with미국, 호주, 벨기에, 독일, 이스라엘, 이탈리아, 대한민국, 러시아 연방, 스페인, 영국, 프랑스, 칠면조, 캐나다, 덴마크, 인도, 폴란드
-
Bingol UniversityAtaturk University아직 모집하지 않음수술 전 불안 | 두려움 | PAIN
-
Cancer Institute and Hospital, Chinese Academy...모병내장 위기로 인해 복잡한 HER2-LOW 절제 불가능한/전이성 유방암중국
-
Weill Medical College of Cornell UniversityNew York University; National Center for Complementary and Integrative Health (NCCIH)모병
-
Shanghai Henlius Biotech모병HER2-LOW 호르몬 수용체 양성 유방암중국
-
Université Victor Segalen Bordeaux 2Nanox International Laboratory (Belgique)완전한
-
Yeon Hee ParkHelsinn Healthcare SA초대로 등록T-DXD로 치료 한 HER2 양성 진행 유방암 환자 | T-DXD로 치료 한 HER2-LOW 진행된 유방암 환자대한민국
-
Eisai Inc.완전한LEC(Low Emetogenic Chemotherapy)를 받기 위해 확인된 악성 질환이 있는 환자 또는 LEC의 마지막 주기 동안 최소한 메스꺼움 및 구토를 경험한 환자미국
-
Istanbul University모병Masticatory Muscle Pain | 근시 통증 증후군 (MP)칠면조